Huawei has launched the Watch D2 in India, positioning it as a health-focused smartwatch with what the company claims are medical-grade blood pressure monitoring and advanced ECG capabilities. The device is priced at ₹34,499, with an introductory offer of ₹33,499 available from October 3 to 5 on Amazon, Flipkart and rtcindia.net.
Health Features With Medical Certifications
According to Huawei, the Watch D2 is certified as a medical device in Europe under CE-MDR regulations and has also received approval from China's National Product Administration. The brand claims its compact air pump and high-precision sensors can deliver accurate blood pressure readings directly from the wrist, reducing the need for bulky external devices. The smartwatch also records single-lead ECG data, which Huawei says can help identify irregular rhythms and potential arrhythmias, providing users with timely insights into cardiovascular health.
The brand is presenting these features as tools that could allow users to take a more proactive role in monitoring cardiovascular health.
In addition, Huawei says the Watch D2 tracks a wide range of other health indicators, from heart rate and SpO₂ to arterial stiffness, skin temperature, sleep quality and stress monitoring. The company claims these features work together to provide a more complete picture of overall wellness.
Other Features
Huawei is also promoting the Watch D2 as a full-fledged smartwatch. It comes with a 1.82-inch AMOLED display rated at 1,500 nits peak brightness, supports over 80 workout modes, and includes personalised reminders, guided routines and health reports that can be shared with doctors. The company says the battery lasts up to seven days on typical use and supports fast charging. On the design front, the watch is available in Black and Gold, with Huawei presenting it as a blend of a medical device and a lifestyle accessory.
The Watch D2 also supports smart connectivity features like call alerts, notifications and weather updates, and is compatible with both Android and iOS devices.
Editorial Takeaway
Huawei's Watch D2 underlines how smartwatch makers are increasingly moving into medically-adjacent territory. The claims of medical-grade accuracy and certifications give it a distinct positioning in a crowded market dominated by fitness-led devices from Apple, Samsung and Garmin. However, the challenge will lie in whether users and healthcare professionals trust wrist-based monitoring as a replacement for traditional equipment, and how consistent the device proves in daily use. For buyers, the Watch D2 represents a premium option that promises deeper health insights, but its long-term value will depend on how reliably these claims translate into real-world accuracy.
